{"schema_version":"1","generated_at":"2026-11-01T05:24:44.450Z","data_as_of":null,"url":"https://www.findmykol.com/kol/cy-wilkins","json_url":"https://www.findmykol.com/kol/cy-wilkins/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"cy-wilkins","name":"Cy Wilkins","credential":"MD","specialty":"Hematology","specialty_raw":"Hematology","therapeutic_area":"Hematology","therapeutic_areas":["Hematology"],"institution":"Memorial Sloan Kettering Cancer Center","institution_url":"https://www.findmykol.com/institution/memorial-sloan-kettering-cancer-center","city":"New York","state":"NY","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1114298056","orcid":"0000-0001-6210-2879","openalex":"A5076551658"},"summary":"Cy Wilkins is a Hematology physician affiliated with Memorial Sloan Kettering Cancer Center. OpenAlex indexes 27 publications with 394 citations (h-index 8); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Hematology"]},"scholarship":{"works_count":27,"cited_by_count":394,"h_index":8,"latest_activity_year":2025,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT02052882","title":"Study of Romiplostim for Chemotherapy Induced Thrombocytopenia","phase":"PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"Memorial Sloan Kettering Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT02052882","trial_url":"https://www.findmykol.com/trial/NCT02052882"}],"source":"trials"},"payments":{"company_count":3,"program_years":{"first":2021,"last":null},"rows_total":4,"shown":3,"withheld":1,"rows":[{"payer":"Pharmacosmos Therapeutics Inc.","program_year":2025,"amount_usd":97.44,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1114298056"},{"payer":"Novartis Pharmaceuticals Corporation","program_year":2025,"amount_usd":34.35,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1114298056"},{"payer":"GENZYME CORPORATION","program_year":2024,"amount_usd":3587.78,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1114298056"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1114298056","source":"payments"},"prescribing":{"data_year":2024,"areas_total":1,"areas_shown":1,"areas":[{"area":"Blood & clotting","share_pct":100,"classes_total":2,"classes":[{"class":"Factor Xa inhibitor","setting":"prescribed","share_pct":68.4,"drugs":[{"name":"Eliquis","share_pct":61.1},{"name":"Xarelto","share_pct":38.9}],"max_beneficiaries":53},{"class":"Low Molecular Weight Heparin","setting":"prescribed","share_pct":31.6,"drugs":[{"name":"Enoxaparin Sodium","share_pct":100}],"max_beneficiaries":34}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":82.8,"facility_pct":17.2},"source":"medicare"},"publications":{"total":24,"shown":5,"withheld":19,"matched_by":"OpenAlex author record","recent":[{"title":"Medical Management of Acute Venous Thromboembolism","year":2025,"journal":"Seminars in Interventional Radiology","source_url":"https://doi.org/10.1055/s-0045-1813235","status":"verified"},{"title":"A target trial emulation to assess the comparative incidences of venous thromboembolism in patients with chemotherapy induced thrombocytopenia treated with romiplostim.","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-21","status":"verified"},{"title":"CXCL9 is a predictive biomarker of survival with IFNγ-targeted therapy in adult HLH patients","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-2996","status":"verified"},{"title":"Use of romiplostim for antineoplastic therapy-induced thrombocytopenia in gynecologic and breast cancers","year":2024,"journal":"Gynecologic Oncology Reports","source_url":"https://doi.org/10.1016/j.gore.2024.101399","status":"verified"},{"title":"Realizing the scope of venous and arterial thrombosis in cyclin-dependent kinase 4/6 inhibitors in hormone positive breast cancer","year":2024,"journal":"European Journal of Internal Medicine","source_url":"https://doi.org/10.1016/j.ejim.2024.09.018","status":"verified"}],"source":"works"},"contact":{"address_1":"1275 YORK AVE","city":"New York","state":"NY","zip":"100656007","phone":"302-598-3369","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1114298056","source":"identity"},"similar":[{"name":"Howard Scher","slug":"howard-scher","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/howard-scher","json_url":"https://www.findmykol.com/kol/howard-scher/profile.json"},{"name":"Robert Motzer","slug":"robert-motzer","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/robert-motzer","json_url":"https://www.findmykol.com/kol/robert-motzer/profile.json"},{"name":"Charles Sawyers","slug":"charles-sawyers","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/charles-sawyers","json_url":"https://www.findmykol.com/kol/charles-sawyers/profile.json"},{"name":"Mark Kris","slug":"mark-kris","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/mark-kris","json_url":"https://www.findmykol.com/kol/mark-kris/profile.json"},{"name":"Joseph Antin","slug":"joseph-antin","institution":"Harvard University","specialty":"Hematology","url":"https://www.findmykol.com/kol/joseph-antin","json_url":"https://www.findmykol.com/kol/joseph-antin/profile.json"},{"name":"Scott Kaufmann","slug":"scott-kaufmann","institution":"Mayo Clinic College of Medicine","specialty":"Hematology","url":"https://www.findmykol.com/kol/scott-kaufmann","json_url":"https://www.findmykol.com/kol/scott-kaufmann/profile.json"},{"name":"Jeffrey Miller","slug":"jeffrey-miller","institution":"University of Minnesota Medical School","specialty":"Hematology","url":"https://www.findmykol.com/kol/jeffrey-miller","json_url":"https://www.findmykol.com/kol/jeffrey-miller/profile.json"},{"name":"Ruben Mesa","slug":"ruben-mesa","institution":"Atrium Health Wake Forest Baptist Comprehensive Cancer Center","specialty":"Hematology","url":"https://www.findmykol.com/kol/ruben-mesa","json_url":"https://www.findmykol.com/kol/ruben-mesa/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":1,"publications":19}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2018-03-30","collected_at":"2026-10-31T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}